Evidence
ACS Chem Neurosci. 2023 Jun 8. doi: 10.1021/acschemneuro.3c00088. Online ahead of print.
ABSTRACT
Dextromethorphan (DXM) was introduced in 1958 as the first non-opioid cough suppressant and is indicated for multiple psychiatric disorders. It has been the most used over-the-counter cough suppressant since its emergence. However, individuals quickly noticed an intoxicating and psychedelic effect if they ingested large doses. DXM’s antagonism at N-methyl-d-aspartate receptors (NMDAr) is thought to underly its efficacy in treating acute cough, but supratherapeutic doses mimic the activity of dissociative hallucinogens, such as phencyclidine and ketamine. In this Review we will discuss DXM’s synthesis, manufacturing information, drug metabolism, pharmacology, adverse effects, recreational use, abuse potential, and its history and importance in therapy to present DXM as a true classic in chemical neuroscience.
PMID:37290117 | DOI:10.1021/acschemneuro.3c00088
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Classics in Chemical Neuroscience: Dextromethorphan (DXM)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A
- Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors
- Psychedelic and dissociative agents in psychiatry: challenges in the treatment
- Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition?
- Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate
- Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate
- Natural Product-Inspired Dopamine Receptor Ligands
- Machine Learning Guided AQFEP: A Fast and Efficient Absolute Free Energy Perturbation Solution for Virtual Screening
- Saroglitazar Enhances Memory Functions and Adult Neurogenesis via Up-Regulation of Wnt/beta Catenin Signaling in the Rat Model of Dementia
- Dual 5-HT(2A) and 5-HT(2C) Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy with Minimal hERG Inhibition for the Treatment of Dementia-Related Psychosis
- Cellular Mechanisms of Cognitive Enhancement: The In Vivo Modulation of the Firing Activity and the Responsiveness of Rat Hippocampal Neurons by Memantine and Alpha7 Nicotinic Acetylcholine Receptor Ligands
- Cellular Mechanisms of Cognitive Enhancement: The In Vivo Modulation of the Firing Activity and the Responsiveness of Rat Hippocampal Neurons by Memantine and Alpha7 Nicotinic Acetylcholine Receptor Ligands
- Cross-Modal Prediction of Spectral and Structural Descriptors via a Pretrained Model Enhanced with Chemical Insights
- Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids
- Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids
- Co-administration of sub-effective doses of the constituents of Crocus sativus L. crocins with those of the antipsychotics clozapine and risperidone counteract memory deficits caused by blockade of the NMDA receptor in rats
- Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M4 Muscarinic Acetylcholine Receptor
- Chaihu Guizhi Decoction Prevents Cognitive, Memory Impairments and Sensorimotor Gating Deficit Induced by N-methyl-d-aspartate Receptor Antibody in Mice
- Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy
- Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy
- iTRAQ-Based Serum Proteomic Analysis Reveals Multifactorial Cellular Function Impairment and Aggravated Systematic Inflammation in Drug-free Obsessive-Compulsive Disorders
- iTRAQ-Based Serum Proteomic Analysis Reveals Multifactorial Cellular Function Impairment and Aggravated Systematic Inflammation in Drug-free Obsessive-Compulsive Disorders
- Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions
- Exposure to Succinate Leads to Steatosis in Non-Obese Non-Alcoholic Fatty Liver Disease by Inhibiting AMPK/PPARalpha/FGF21-Dependent Fatty Acid Oxidation
- Differences in the Ability of Lactic Acid Bacteria To Prevent Acute Alcohol-Induced Liver Injury via the Gut Microbiota-Bile Acid-Liver Axis
- Large Language Models for Inorganic Synthesis Predictions
- Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications
- Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening
- pKa Calculations of GPCRs: Understanding Protonation States in Receptor Activation
- Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors
- Applying Spatial Metabolomics To Investigate Age- and Drug-Induced Neurochemical Changes
- iTRAQ-Based Serum Proteomic Analysis Reveals Multifactorial Cellular Function Impairment and Aggravated Systematic Inflammation in Drug-free Obsessive-Compulsive Disorders
- iTRAQ-Based Serum Proteomic Analysis Reveals Multifactorial Cellular Function Impairment and Aggravated Systematic Inflammation in Drug-free Obsessive-Compulsive Disorders
- Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases
- Bohemian Rhapsody of Future Drug Delivery Systems: Rational Changes Necessary for the Next Revolution
- KETAMINE: Neural- and network-level changes
- Self-Driving Laboratories for Chemistry and Materials Science
- Elucidating the Selective Mechanism of Drugs Targeting Cyclin-Dependent Kinases with Integrated MetaD-US Simulation
- Elucidating the Selective Mechanism of Drugs Targeting Cyclin-Dependent Kinases with Integrated MetaD-US Simulation
- Psychoactive substances for the treatment of neuropsychiatric disorders
- Molecular Mechanism of Fusarium Fungus Inhibition by Phenazine-1-carboxamide
- Multilevel Printed Wearable Radio-Frequency Intelligent Identification Platform for Object Recognition
- Psychoactive substances for the treatment of neuropsychiatric disorders
- The Black Book of Psychotropic Dosing and Monitoring
- New Opportunities for Organic Synthesis with Superheated Flow Chemistry
- OpenChemIE: An Information Extraction Toolkit for Chemistry Literature
- Near-Infrared Fluorescent Probe Reveals Elevated Mitochondrial Viscosity during Acute Alcoholic Liver Injury
- Near-Infrared Fluorescent Probe Reveals Elevated Mitochondrial Viscosity during Acute Alcoholic Liver Injury
- Discovering Dually Active Anti-cancer Compounds with a Hybrid AI-structure-based Approach
- Proton Conducting Neuromorphic Materials and Devices
- Is there evidence for using ketamine among individuals with dementia?
- Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro
- Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro
- Innovative Multistage ML-QSAR Models for Malaria: From Data to Discovery
- MMFA-DTA: Multimodal Feature Attention Fusion Network for Drug-Target Affinity Prediction for Drug Repurposing Against SARS-CoV-2
- Efficient Deep Model Ensemble Framework for Drug-Target Interaction Prediction
- Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor
- Early-life risperidone alters locomotor responses to apomorphine and quinpirole in adulthood
- Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money
- Hybrid Diffusion Model for Stable, Affinity-Driven, Receptor-Aware Peptide Generation
- The effect of phencyclidine-mediated blockade of NMDA receptors in the early postnatal period on glutathione and sulfur amino acid levels in the rat brain as a potential causative factor of schizophrenia-like behavior in adulthood
- Advances in Mood Disorder Pharmacotherapy: Evaluating New Antipsychotics and Mood Stabilizers for Bipolar Disorder and Schizophrenia
- Ursolic Acid Ameliorates Alcoholic Liver Injury through Attenuating Oxidative Stress-Mediated Ferroptosis and Modulating Gut Microbiota
- Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
Evidence Blueprint
Classics in Chemical Neuroscience: Dextromethorphan (DXM)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Classics in Chemical Neuroscience: Dextromethorphan (DXM)
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Preparation, characterization, and in vitro/vivo evaluation of a multifunctional electrode coating for cochlear implants
- Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A
- Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors
- RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
- Factors influencing behavioral cough suppression therapy in children with nonspecific chronic cough
- Concise and Scalable Radiosynthesis of (+)-[18F]MDL100907 as a Serotonin 5-HT2A Receptor Antagonist for PET
- Characterization of (R)- and (S)-[18F]OF-NB1 in Rodents as Positron Emission Tomography Probes for Imaging GluN2B Subunit-Containing N-Methyl-d-Aspartate Receptors
- Serotonin Signaling through Lipid Membranes
- Synthesis and Preclinical Evaluation of 22-[18F]Fluorodocosahexaenoic Acid as a Positron Emission Tomography Probe for Monitoring Brain Docosahexaenoic Acid Uptake Kinetics
- Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer's Agents: Synthesis, Biological, and Molecular Docking Studies
- Use of artificial intelligence to develop predictive algorithms of cough and PCR-confirmed COVID-19 infections based on inputs from clinical-grade wearable sensors
- Ketamine, an Old-New Drug: Uses and Abuses
- Amylin in Alcohol Addiction: A Potential New Treatment Target or an Adjuvant to Other Treatments?
- Psychedelic and dissociative agents in psychiatry: challenges in the treatment
- Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort
- Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?
- Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3
- The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
- Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition?
- Effects of the Synthetic Cathinone α-Pyrrolidinobutiothiophenone (α-PBT) on Discriminative Stimulus Effects and Intracranial Self-Stimulation Thresholds in Male Rats
- Exploring the Function of (+)-Naltrexone Precursors: Their Activity as TLR4 Antagonists and Potential in Treating Morphine Addiction
- Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate
- Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate
- Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors
- Amyloid Targeting Red Emitting AIE Dots for Diagnostic and Therapeutic Application against Alzheimer's Disease
- Evolutionary Multiobjective Molecule Optimization in an Implicit Chemical Space
- Evolutionary Multiobjective Molecule Optimization in an Implicit Chemical Space
- Natural Product-Inspired Dopamine Receptor Ligands
- Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid
- Current concepts in ketamine therapy in the emergency department
- Identification of an Antagonist Targeting G Protein and β-Arrestin Signaling Pathways of 5-HT7R
- Channel Activities of the Full-Length Prion and Truncated Proteins
- Correction to "Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease"
- Machine Learning Guided AQFEP: A Fast and Efficient Absolute Free Energy Perturbation Solution for Virtual Screening
- Saroglitazar Enhances Memory Functions and Adult Neurogenesis via Up-Regulation of Wnt/beta Catenin Signaling in the Rat Model of Dementia
- COVID-19 symptom identification using Deep Learning and hardware emulated systems
- Novel Inhibitory Site Revealed by XAP044 Mode of Action on the Metabotropic Glutamate 7 Receptor Venus Flytrap Domain
- Leveraging AI and Machine Learning to Develop and Evaluate a Contextualized User-Friendly Cough Audio Classifier for Detecting Respiratory Diseases: Protocol for a Diagnostic Study in Rural Tanzania
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Research Report: A Link between Sertraline Treatment and Susceptibility to (Mis)information
- Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study
- Protective Effect of Hop Ethyl Acetate Extract on Corticosterone-Induced PC12 and Improvement of Depression-like Behavior in Mice
- Prenatal Fluoxetine Exposure Influences Glucocorticoid Receptor-Mediated Activity in the Prefrontal Cortex of Adolescent Rats Exposed to Acute Stress
- Dual 5-HT(2A) and 5-HT(2C) Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy with Minimal hERG Inhibition for the Treatment of Dementia-Related Psychosis
- Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
- Deus Ex Machina? The Rise of Artificial Intelligence in Toxicology
- Cellular Mechanisms of Cognitive Enhancement: The In Vivo Modulation of the Firing Activity and the Responsiveness of Rat Hippocampal Neurons by Memantine and Alpha7 Nicotinic Acetylcholine Receptor Ligands
- Cellular Mechanisms of Cognitive Enhancement: The In Vivo Modulation of the Firing Activity and the Responsiveness of Rat Hippocampal Neurons by Memantine and Alpha7 Nicotinic Acetylcholine Receptor Ligands
- Patient Brain Organoids Identify a Link between the 16p11.2 Copy Number Variant and the RBFOX1 Gene
- SDDSynergy: Learning Important Molecular Substructures for Explainable Anticancer Drug Synergy Prediction
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 Isoforms
- On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model
- Cross-Modal Prediction of Spectral and Structural Descriptors via a Pretrained Model Enhanced with Chemical Insights
- Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids
- Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids
- Evaluating the Atypical Aging Potential Development in Sparkling Wines Can Be Achieved by Assessing the Base Wines at the End of the Alcoholic Fermentation
- The Dynamics of Resting-State EEG and Salivary Trace Elements in Patients with Obsessive-Compulsive Disorder
- Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation
- Isolation and Identification of the High-Affinity DNA Aptamer Target to the Brain-Derived Neurotrophic Factor (BDNF)
- Similar Binding Modes of cGMP Analogues Limit Selectivity in Modulating Retinal CNG Channels via the Cyclic Nucleotide-Binding Domain
- Soft Bioelectronics Using Nanomaterials and Nanostructures for Neuroengineering
- Analysis of Vocal Signatures of COVID-19 in Cough Sounds: A Newer Diagnostic Approach Using Artificial Intelligence